Qingdao Baheal Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for QINGDAO BAHEAL PHARM, and what generic and branded alternatives to QINGDAO BAHEAL PHARM drugs are available?
QINGDAO BAHEAL PHARM has five approved drugs.
Summary for Qingdao Baheal Pharm
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Qingdao Baheal Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qingdao Baheal Pharm | FOLIC ACID | folic acid | TABLET;ORAL | 091145-001 | Jul 12, 2013 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Qingdao Baheal Pharm | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209993-001 | Dec 27, 2018 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Qingdao Baheal Pharm | CELECOXIB | celecoxib | CAPSULE;ORAL | 208856-003 | Aug 7, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Qingdao Baheal Pharm | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209993-002 | Dec 27, 2018 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Qingdao Baheal Pharm | DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 210599-002 | Apr 17, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
